

Cover Story
NCI officials said they plan to hold a series of meetings with clinical trials group chairs and group financial officers in order to fine-tune the new National Clinical Trials Network.
In Brief
Trending Stories
- Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable” - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Lou Weiner to step down as director of Georgetown’s Lombardi CCC after 18 years
- After a year, Stephenson institute sees a broader role in funding pancreatic cancer research, fostering collaborations
“We are not just funding research. We are building a trusted community.” - Trump administration announces “major crackdown” on healthcare fraud
- FDA issues draft guidance on accelerating development of individualized therapies for ultra-rare diseases











